We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.
Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.
We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations.
What you'd do
- The candidate will help to devise and plan a research project in the Kite vector core pertaining to utilizing and optimizing viral vectors desigend for cell therapy.
- Carry out the research project under the supervision and guidance of the vector core lead.
- Perform data analyses of their results to guide further experiments
- Showcase your work with a final presentation (PPT) near the conclusion of your internship
- Must be at least 18 years of age at the start of the internship.
- Must be enrolled full‑time in a Bachelor’s, Master’s, MBA, JD or PhD program at a nationally accredited U.S. college or university, with continued full‑time enrollment required in the Fall semester following the internship.
- Must be currently enrolled as an undergraduate (freshman, sophomore, junior, or senior) or as a graduate/doctoral student.
- Must have a minimum overall cumulative GPA of 2.8 at the time of application and hire (official transcripts will be requested).
- Must be independently authorized to work in the United States now and in the future (current or future work authorization must not require school or employer sponsorship).
- Must be able to commit to a full‑time internship lasting 10–12 consecutive weeks between May and August.
- Starts
- 2026-09-14